Navigation Links
Chester County Biopharmaceutical Firm to Expand, Create 151 New Jobs
Date:9/10/2012

HARRISBURG, Pa., Sept. 10, 2012 /PRNewswire-USNewswire/ -- Governor Tom Corbett announced today that ViroPharma Inc. – a homegrown biopharmaceutical company – will expand its operations in Exton, Chester County and create 151 new, high-paying jobs. 

"ViroPharma is a true Pennsylvania success that continues to grow and create jobs in the region," said Corbett. "What started as a small team of entrepreneurs in Exton has now evolved into an international biopharmaceutical company employing hundreds of Pennsylvanians."

ViroPharma will nearly double its current available space by leasing an additional 71,000-square feet of office space to accommodate planned growth. The expansion will enable the company to retain its existing 188 employees and create at least 151 new jobs within three years.

The company received a $583,000 funding offer from the Department of Community and Economic Development, including a $130,000 Pennsylvania First grant and $453,000 in Job Creation Tax Credits.  

"For us it is about growth. ViroPharma has been in Exton for many years and we love our home here," said ViroPharma President and CEO Vincent J. Milano. "We're committed to this area for the long-term and look forward to creating opportunities in this community."

The project was coordinated by the Governor's Action Team, or GAT, economic development professionals who work directly with businesses that are considering locating or expanding in Pennsylvania. GAT worked with the Chester County Economic Development Council (CCEDC) to support ViroPharma's expansion.

"Chester County is fortunate to have companies like ViroPharma who continually innovate and reinvent themselves," said CCEDC President and CEO Gary Smith.  "Their expansion is the latest evidence that the life science community in Chester County is alive and well."

Founded in 1994 by a small team of entrepreneurial scientists in Exton, ViroPharma is focused on developing drugs for rare diseases in which there is an unmet medical need. The organization has grown into an international biopharmaceutical company with significant operations in Europe, in addition to Pennsylvania.

For more information about ViroPharma, visit www.viropharma.com.  

For more information on the Governor's Action Team and Pennsylvania's other economic development initiatives, visit www.newPA.com or call 1-866-466-3972.

Media contacts:

Kelli Roberts, Governor's Office; 717-783-1116
Theresa Elliott, DCED; 717-783-1132


'/>"/>
SOURCE Pennsylvania Office of the Governor
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Rochester Medical Reports Third Quarter Results
2. Rochester Medical Announces Third Quarter 2012 Earnings Conference Call Friday, July 27, 2012
3. Rochester Medical Introduces Magic3® Coude Tip Hydrophilic Intermittent Catheter
4. Saddleback Memorial Named First Robotic Training Epicenter for Gynecologic Surgery in Orange County
5. Governor Corbett: Lancaster County Commercial Lab to Expand, Create 200 New Jobs
6. National Press Club to Host "NEWSMAKER" with PhRMA CEO to Discuss Policy, Budget Threats to Biopharmaceutical Research
7. Alder Biopharmaceuticals Receives $3.5 Million Milestone Payment from Bristol-Myers Squibb for Initiation of Phase 2 Clinical Trial of ALD518/BMS-945429 in Crohns Disease
8. The Thousand-Year Business Model for a Modern Biopharmaceutical Company
9. Biopharmaceutical Service Providers Announce Collaborative Opening of Boston, MA Office
10. Keryx Biopharmaceuticals, Inc. To Host Conference Call on Second Quarter 2012 Financial Results
11. PAREXEL Launches The PAREXEL BioPharm Unit To Meet The Critical Development Goals Of Small And Mid-Sized Biopharmaceutical Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Research and Markets has announced the ... Tests" report to their offering. ... The World Market for Companion Diagnostics covers the ... analysis in the report includes the following: ... Kits) by Region (N. America, EU, ROW), 2015-2020 , ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, ... Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments in ... the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out ... family verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers ... would throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway ... call for a minimum wage raise to $12 an hour by 2020 and then adjusting ... restore the lost value of the minimum wage, assure the wage floor does not erode ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital ... area economy by obtaining investment capital for emerging technology companies. SCP has ... have already resulted in more than a million dollars of capital investment for ...
(Date:6/24/2016)... ... June 24, 2016 , ... Finally, a bruise cream that really ... cream can be incorporated into the post-surgical treatment plans of a variety of other ... dermaka cream is very effective for bruising and causes a rapid resolution of bruising ...
Breaking Medicine News(10 mins):